All Updates

RALEIGH, N.C. – As North Carolina lawmakers begin the 2026 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize HB567 , legislation that will ease the burden of cancer on North Carolinians by increasing access to biomarker testing for those with state-regulated health

WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.

NASHVILLE, Tenn. – The Tennessee Senate unanimously passed a bill to expand coverage of biomarker testing on Thursday, April 16, sending it to the desk of Gov. Bill Lee. SB0435 would expand coverage of biomarker testing for patients enrolled in state employee health insurance plans and TennCare.

Advocates, including cancer patients, survivors and caregivers with the American Cancer Society Cancer Action Network (ACS CAN) applaud the Guam Department of Public Health and Social Services for updating the school health requirements to include the Human Papillomavirus (HPV) vaccine. The requirements will initially apply to students entering sixth, ninth,

WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.

Cancer Advocates Applaud the Senate’s Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.

Cancer Advocates Applaud the Senate’s Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.

The 2026 legislative session in Annapolis brought three key developments in tobacco control policy. First, lawmakers declined to advance legislation that would have created an exemption to the Clean Indoor Air Act by expanding the number of businesses that allow indoor cigar smoking. This was met with praise by cancer survivors and health advocates, but, as one survivor advocate with the American Cancer Society Cancer Action Network (ACS CAN) described it, this session “we took one step forward and two steps back.”

DES MOINES, Iowa – “Iowa has the 2nd highest cancer rates in the country, and our cancer incidence continues to rise year over year. The state legislature’s vote to restrict access to the Human Papillomavirus (HPV) vaccine for minors will make our cancer crisis worse. Childhood vaccinations are a powerful